Last $101.71 USD
Change Today -0.03 / -0.03%
Volume 325.9K
SIAL On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 5:20 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Snapshot

Open
$101.96
Previous Close
$101.74
Day High
$102.22
Day Low
$101.29
52 Week High
07/8/14 - $102.69
52 Week Low
08/29/13 - $81.86
Market Cap
12.1B
Average Volume 10 Days
553.0K
EPS TTM
$4.11
Shares Outstanding
118.8M
EX-Date
08/27/14
P/E TM
24.8x
Dividend
$0.92
Dividend Yield
0.88%
Current Stock Chart for SIGMA-ALDRICH (SIAL)

sigma-aldrich (SIAL) Related Businessweek News

No Related Businessweek News Found

sigma-aldrich (SIAL) Details

Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment worldwide. Its chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. The company sells its products to commercial laboratories, pharmaceutical companies, industrial companies, universities, diagnostics companies, biotechnology companies, electronics companies, hospitals, governmental institutions, and non-profit organizations. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.

9,100 Employees
Last Reported Date: 04/24/14
Founded in 1951

sigma-aldrich (SIAL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $876.9K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $465.4K
Executive Vice President and President of App...
Total Annual Compensation: $437.7K
Executive Vice President and President of SAF...
Total Annual Compensation: $386.5K
Executive Vice President and President of Res...
Total Annual Compensation: $350.0K
Compensation as of Fiscal Year 2013.

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corporation Announces Quarterly Cash Dividend, Payable on September 15, 2014

Sigma-Aldrich Corporation announced a quarterly cash dividend of $0.23 per common share. The dividend was approved by the company's Board of Directors on June 23, 2014 and is payable on September 15, 2014 to shareholders of record at the close of business on August 29, 2014.

Sigma-Aldrich Seeks Acquisitions

Sigma-Aldrich Corporation (NasdaqGS:SIAL) seeks acquisitions. "I think as Quintin and others have said before, we are a very ROIC-driven company, and that is one of the main things we look at when we evaluate acquisitions or any type of investment. We have to, obviously, exceed our cost of capital. We have to look at how in the long run or short run can that be added to our ROIC, which is near 20% right now. So we are looking at all investments and how that can affect us on the ROIC front. From a cash standpoint, yes, we do have a lot of cash. We do have most of our cash, if not all is outside of the US. We do look for strategies to bring back all that cash to the US, but we utilized our cash in the US on a prudent basis, as we always have. This year is the 39th consecutive year we've increased our dividend, so we pay a dividend, which is rare for our space. We continue to buy back shares, usually about 1.5 million a year. It has been fairly consistent the past four or five years. So we do spend some money on the dividend and our share repurchases. Our capital expense this year is expected to be around $130 million or so, so we like to build from within. And that is a real model that we have exercised over the years since we like to grow organically and build our facilities out, make sure they are safe for all of our employees, and we provide safe products," said Mike Hollenkamp, Sigma-Aldrich Corporation - Vice President & Treasurer.

Solvo Biotechnology Signs Marketing Agreement with Sigma-Aldrich

Solvo Biotechnology has signed an agreement with Sigma-Aldrich to market Solvo Biotechnology products in the United States and Canada. Solvo Biotechnology announced that agreement would serve to strengthen the company's market position in North America.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $101.71 USD -0.03

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 2,701 INR +50.05
FMC Corp $69.26 USD +0.12
International Flavors & Fragrances Inc $104.25 USD +0.32
Waters Corp $102.80 USD +0.61
Westlake Chemical Corp $85.64 USD +1.28
View Industry Companies
 

Industry Analysis

SIAL

Industry Average

Valuation SIAL Industry Range
Price/Earnings 24.8x
Price/Sales 4.5x
Price/Book 4.1x
Price/Cash Flow 24.4x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit www.sigmaaldrich.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.